Position in GSK
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$285,951
New position
Shares Held
5,455
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#611
of 1,032 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Empirical Asset Management, LLC holds $14,808,473 across 9 Drug Manufacturers - General names. GSK ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,661 | $5,590,543 | |
| 2 | JNJ |
Johnson & Johnson
|
8,572 | $2,177,030 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,535 | $1,996,247 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
13,735 | $1,735,279 | |
| 5 | ABBV |
AbbVie Inc.
|
5,575 | $1,402,893 | |
| 6 | AMGN |
Amgen Inc
|
2,925 | $1,059,201 | |
| 7 | PFE |
Pfizer Inc
|
13,097 | $315,375 | |
| 8 | GSK |
GSK plc
This page
|
5,455 | $285,951 |
All Filings in GSK
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $285,951 | 5,455 | Shares | Sole | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||